

U-Defi, Inc. is a skincare company developing safe and effective anti-aging creams based on individual customers’ skin profiles.
Market:
The problem with trying to find the right skin care product is that consumers can’t tell which anti-aging creams are best for their specific skin type. The result is a trial and error selection process that is both expensive and inconvenient. The US skincare market is expected to cross $11 billion in 2018, however with only one dermatologist per 27 thousand people, the access to specialized skincare is low. U-Defi is targeting the 16 million women who spend $1 billion each year to find and purchase their anti aging skincare products.
Technology:
U-Defi offers anti-aging creams tailored for every unique customer. Upon signing up, customers receive a testing kit that will be analyzed for biomarker levels associated with aging. U-Defi uses a proprietary algorithm to match the customer to formulations based on the results of the biomarkers analysis. The customer will receive a second kit six months later, which allows the customer to track their progress and provides U-Defi with updated data so they can fine-tune the customized product.
Advantages:
- Tailored to each unique individual
- Use of skin biomarkers to customize formula
- Proprietary technology to match skin needs
- All female founders
- Testing kits delivered to the customer’s home
Graduated Companies
- Adaptix
- Aneeve
- Aneuvo
- Appia Bio
- Bluefin Foods
- CarbonBuilt
- Carbonics
- Charlot Biosciences
- CBD Research Institute
- Cellmic
- Concrete-AI
- Craytex
- CytoLumina
- DARTS Sciences
- Electronucleics
- EP Dynamics
- Ferrologix
- Horizon PV
- Inspira
- Inston
- InvVax
- Kelvi
- Keyssa
- Kythera Biopharmaceuticals
- Librede
- Lucendi
- Matrix Sensors, Inc.
- MAX BioPharma
- MediSens Wireless
- MicrobeDx
- Millibatt
- MyoGene Bio
- Myst Therapeutics
- Nammi Therapeutics
- NanoClear
- NanoElectronic Imaging
- NanoH₂O
- Nanopixel Technologies
- National Institute of Cannabinoid Research (NICR)
- Octant
- Omega Biosystems
- Orchard Therapeutics
- Polyradiant
- Qwixel Therapeutics
- Restore Technologies
- Sardona Therapeutics
- SELFA
- Sixal
- Spectradyne Particle Analysis
- Tempo Therapeutics
- TrueCath
- U-Defi
- Valerion Therapeutics
- Vivibaba
- Zenomics
- Back to Portfolio